期刊文献+

人巨细胞病毒IE1真核表达载体的构建与表达 被引量:2

Construction and Expression of Eukaryotic Expression Vector of Human Cytomegalovirus IE1
下载PDF
导出
摘要 目的构建人巨细胞病毒(HCMV)IE1真核表达载体,观察其在真核细胞内的表达,为HC-MVIE1核酸疫苗的相关研究奠定基础。方法将质粒pNEB193-IE1用SalⅠ、BamHⅠ双酶切与载体pEGFP-C1连接构建重组载体pEGFP-C1-IE1;双酶切鉴定后,取重组载体pEGFP-C1-IE1用EcoRⅠ、HindⅢ双酶切与载体pcDNA3.1(-)连接构建重组质粒pcDNA3.1(-)-IE1,双酶切和测序鉴定;将重组质粒pcDNA3.1(-)-IE1转染HeLa细胞,RT-PCR检测IE1 mRNA的表达。结果重组载体pEGFP-C1-IE1和pcDNA3.1(-)-IE1双酶切后均可切出约1 476 bp目的片段;重组载体pcDNA3.1(-)-IE1测序结果登录GenBank,作BLAST分析,含有1 476 bp目的基因片段,无碱基错配和移码突变,与读码框完全一致;转染重组载体pcDNA3.1(-)-IE1的细胞中可扩增出约1 476 bp的目的条带。结论成功地构建了真核表达载体pcDNA3.1(-)-IE1,且其能在真核细胞内表达。 Objective To establish the substructure of Human Cytomegaloviru (HCMV) IE1 DNA vaccine, this study was designed to construct a recolnbinant eukaryotic expression vector of IE1 and analyze its expression in eukaryotic cells. Methods HCMV IE1 gene fragment obtained from pNEB193 - IE1 by enz)ane digestion was inserted into expression vector pEGFP - C1 and was confiixned by Sal I/BamH I. Then the recombinant vectorpEGFP - C1 - IE1 cut by enzyne digestion was inseded into eukaryotic expression vector pcDNA3.1 ( - ) and confirmned by EcoR I/Hind Ⅲ and sequencing. The recombinant eukaryotic expression vector pcDNA3.1 ( - ) - IE1 was transfected into HeLa cells. The expressed product of IE1 mRNA was amplified by RT- PCR. Results Restricted enzyme analysis and DNA sequencing showed that recombinant vectors were correct. The expressed product of HC- MV IE1 mRNA could be be detected in HeLa cells. Conclusion The recombinant eukaryotie expression vector of HCMV IE1 was successfully constructed, HCMV IE1 mRNA could be expressed in HeLa ceils.
出处 《南华大学学报(医学版)》 2008年第1期5-7,11,共4页 Journal of Nanhua University(Medical Edition)
基金 湖南省财政厅 教育厅资助项目(05C472)
关键词 人巨细胞病毒(HCMV) IEl 表达 human cytolnegatovirus(ltCMV) IE1 expression
  • 相关文献

参考文献12

  • 1Kano Y, Shiohara T. Current understanding of cytomegalovims infection in immunocompetent individuals[J]. J Dar Sci, 2000,22(3):196- 204.
  • 2Gilbert MJ, Riddell SR, Plachter B, et al . Cytomegalovims selectively blocks antigen processing and presentation of its immediate - early gene product[J]. Nature, 1996, 383 (6602): 720 - 722.
  • 3Gibson L, Piccinini G, Lilleri D, et. al. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8^+ T cell responses in children with congenital or postnatal human cytomegalovims infection [ J ]. Immunology, 2004, 172 : 2256 - 2264.
  • 4Burd T, Kirchner A, Hoffmeister B, et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1 specific CD8 T cells [J]. Exp Medi, 2005, 201(7): 1031- 1036.
  • 5Gyulai Z, Endresz V, Burian K, et al. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1 - Exon4, gB, pp150, and pp28 in healthy individuals : reevaluation of prevalence of IE1 - specific CTLs[J]. J Infect Dis, 2000, 181(5) : 1537 - 1546.
  • 6黄培堂.分子克隆实验指南.第3版[M].北京:科学出版社,2002.
  • 7李雪丹,金红.先天巨细胞病毒感染致畸机制研究进展[J].国外医学(病毒学分册),2004,11(4):128-128. 被引量:15
  • 8Eryol NK, Kilic H, Gul A, et al . Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease [ J]. Int Heart, 2005, 46 : 205 - 220.
  • 9Castillo JP, Frame FM, Rogoff HA, et al. Human cytomegalovirus IEI - 72 activates ataxia telangiectasia mutated kinase and a p53/p21 - mediated growth alwest response[J]. Virology, 2005, 79(17): 11467- 11475.
  • 10Kim J, Kwon Y J, Park ES, et al. Humun cytomegalovims IE1 plays role in resistance to apoptosis with etopside in cancer cell line by Cdk2 accumulation [ J ]. Microbiol Immunol, 2003, 47(12):959 - 967.

二级参考文献24

  • 1Navarro D, Paz P, Tuzigov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of refection from cell from cell, and fusion of infected cells. Virology, 1993, 197:143-158.
  • 2Maconochie M, Nonchev S, Morrison A, etal. Paralogous HOX enes: Function and regulation Annu Rev Genet, 1996, 30: 529-556.
  • 3Yurochko AD, Huang ES. Human cytomegalovirus binding to human monocytes induced immunoregulatory gene expression. J Immunol, 1999,162: 4806-4816.
  • 4Britt WJ, Mach MJ. Human cytomegalovirus glycoproteins. Intervirology, 1996, 39: 401-412.
  • 5Chou, S.and Dennison, K.M. Analysis of interstram variation cytomegalovirus glycoprotem B sequences encoding neutralization-related epitopes. J infect Dis, 1991, 163:1229-1234.
  • 6Shepp, D.H. Match, M.E., Lipson, SM. and Pergolizzi, R. GA fifth human cytomegalovirus glycoprotein B genotype. Res Virol, 1998, 149:109-114.
  • 7Daniel E, Gillian M, Scott, et al. Human Cytomegalovirus Strains Associated With Congenital and Perinatal Infections. Journal of Medical Virology, 2000, 61: 481-487.
  • 8Fries 13C, Chou S, Boeckh M,et al. Frequency distribution of cytomegal.ov, i. rus envolope glycoprotein genotypes bone marrow transplant recipients. Journal of lnfection Disease, 1994, 169:769-774.
  • 9Bongarts A, Von Laer D; Vogelberg C, etal. Glycoprotein B genotype of human cytomegalovirus Distribution in HIV infected patients. Scandinavian Journal of Infectious Disease, 1996, 28:447-449.
  • 10Bale JF Jr, Murph JR, Demmler GJ, et al. Intrauterine cytomegalovims infection and glycoprotein B genotype. J Infect Dis, 2000,182:933-936.

共引文献15

同被引文献18

  • 1刘安元,陈琳,万艳平,陈熙,朱翠明,余敏君,曹清香.人巨细胞病毒IE1蛋白促进巨噬细胞分泌IL-1β、TNF-α及凋亡[J].现代免疫学,2008,28(1):12-15. 被引量:1
  • 2李雪丹,金红.先天巨细胞病毒感染致畸机制研究进展[J].国外医学(病毒学分册),2004,11(4):128-128. 被引量:15
  • 3Castillo JP,,Frame FM,Rogoff HA,et al.Human Cytomegalovirus IE1-72Activates Ataxia Telangiectasia Mutated Kinase and a p53/p21-Mediated Growth Arrest Response. Journal of Virology . 2005
  • 4Lee K,Jeon K,Kim VN,et al.Downregulation of GFAP,TSP-1,and p53in human glioblastoma cell line,U373MG,by IE1protein from human cytomegalovirus. Glia . 2005
  • 5Schleiss M.Progress in cytomegalovirus vaccine developments. Herpers . 2005
  • 6Burd T,Kirchner A,Hoffmeister B,et al.Protection from cy-tomegalovirus after transplantation is correlated with immediate early1-specific CD8T cells. Exp Medi . 2005
  • 7Hung CF,Wu TC.Improving DNA vaccine potency via modification of professional antigen presenting cells. Current Opinion in Molecular Therapeutics . 2003
  • 8Reddehase,MJ.Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nature Reviews Immunology . 2002
  • 9Gibson L,Piccinini G,Lilleri D,et al.Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CDS(+) Y cell responses in children with congenital or postnatal human cytomegalovirus infection. Journal of Immunology . 2004
  • 10Eryol NK,Kilic H,Gul A,et al.Are the high levels of cy2 tomegalo-virus antibodies a determinant in the development of coronary arterydisease. Int Heart J . 2005

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部